| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neovascularization, Pathologic | 42 | 2024 | 2635 | 3.320 |
Why?
|
| Matrix Metalloproteinase 9 | 23 | 2018 | 631 | 3.030 |
Why?
|
| Matrix Metalloproteinase 2 | 30 | 2022 | 459 | 2.960 |
Why?
|
| Matrix Metalloproteinases | 20 | 2019 | 392 | 2.740 |
Why?
|
| Lipocalins | 11 | 2016 | 161 | 2.250 |
Why?
|
| Acute-Phase Proteins | 10 | 2016 | 250 | 2.130 |
Why?
|
| Metalloendopeptidases | 22 | 2011 | 389 | 1.860 |
Why?
|
| Neovascularization, Physiologic | 14 | 2014 | 1347 | 1.440 |
Why?
|
| Vascular Endothelial Growth Factor A | 19 | 2022 | 3493 | 1.270 |
Why?
|
| Cell Movement | 16 | 2024 | 5195 | 1.260 |
Why?
|
| Breast Neoplasms | 23 | 2024 | 20981 | 1.230 |
Why?
|
| Fibroblast Growth Factor 2 | 9 | 2022 | 588 | 1.220 |
Why?
|
| Intercellular Adhesion Molecule-1 | 7 | 2023 | 1128 | 1.210 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2022 | 506 | 1.170 |
Why?
|
| Extracellular Matrix | 14 | 2020 | 1720 | 1.150 |
Why?
|
| STAT3 Transcription Factor | 2 | 2024 | 872 | 1.110 |
Why?
|
| Angiogenesis Inhibitors | 14 | 2016 | 2047 | 1.050 |
Why?
|
| Liposomes | 8 | 2019 | 783 | 1.050 |
Why?
|
| ADAM Proteins | 6 | 2015 | 238 | 1.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 9 | 2022 | 72 | 1.000 |
Why?
|
| Cell Line, Tumor | 29 | 2024 | 16947 | 0.990 |
Why?
|
| Adipocytes | 2 | 2024 | 1184 | 0.980 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2014 | 504 | 0.960 |
Why?
|
| Blood-Brain Barrier | 3 | 2020 | 1027 | 0.960 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2016 | 4510 | 0.910 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 17 | 2009 | 97 | 0.910 |
Why?
|
| Pelvic Pain | 4 | 2021 | 292 | 0.900 |
Why?
|
| Immunoconjugates | 2 | 2023 | 963 | 0.890 |
Why?
|
| Cell Proliferation | 21 | 2024 | 10421 | 0.830 |
Why?
|
| Drug Delivery Systems | 5 | 2020 | 2223 | 0.780 |
Why?
|
| Urologic Diseases | 3 | 2020 | 247 | 0.780 |
Why?
|
| Endocytosis | 3 | 2020 | 950 | 0.720 |
Why?
|
| Transcytosis | 1 | 2019 | 44 | 0.660 |
Why?
|
| Endothelial Cells | 13 | 2019 | 3550 | 0.660 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2020 | 187 | 0.660 |
Why?
|
| Integrin alpha2 | 1 | 2019 | 39 | 0.660 |
Why?
|
| Drug Carriers | 2 | 2019 | 706 | 0.640 |
Why?
|
| Cattle | 18 | 2014 | 3819 | 0.620 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 7 | 2010 | 151 | 0.610 |
Why?
|
| Flow Cytometry | 4 | 2019 | 5870 | 0.610 |
Why?
|
| Progeria | 2 | 2018 | 188 | 0.600 |
Why?
|
| Menopause | 2 | 2024 | 1646 | 0.600 |
Why?
|
| Blood Vessels | 4 | 2012 | 1111 | 0.590 |
Why?
|
| Neoplasms | 15 | 2020 | 22125 | 0.570 |
Why?
|
| Nanoparticles | 3 | 2019 | 1959 | 0.570 |
Why?
|
| Elastic Modulus | 1 | 2018 | 211 | 0.550 |
Why?
|
| Time-Lapse Imaging | 1 | 2018 | 194 | 0.550 |
Why?
|
| Holography | 1 | 2017 | 80 | 0.530 |
Why?
|
| Up-Regulation | 9 | 2017 | 4111 | 0.530 |
Why?
|
| Sports | 1 | 2021 | 705 | 0.500 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 736 | 0.480 |
Why?
|
| Corpus Luteum | 5 | 2011 | 81 | 0.470 |
Why?
|
| Neoplasm Metastasis | 9 | 2020 | 4908 | 0.470 |
Why?
|
| Estrous Cycle | 4 | 2011 | 65 | 0.460 |
Why?
|
| Ovarian Neoplasms | 4 | 2019 | 4853 | 0.460 |
Why?
|
| Plasminogen | 5 | 2003 | 143 | 0.440 |
Why?
|
| Chondrosarcoma | 4 | 2001 | 295 | 0.430 |
Why?
|
| Cartilage | 5 | 1999 | 807 | 0.420 |
Why?
|
| Membrane Proteins | 6 | 2015 | 7844 | 0.420 |
Why?
|
| Animals | 91 | 2022 | 168083 | 0.410 |
Why?
|
| Blood Proteins | 1 | 2018 | 1172 | 0.410 |
Why?
|
| Astrocytes | 1 | 2020 | 1341 | 0.400 |
Why?
|
| Endothelium, Vascular | 18 | 2007 | 4421 | 0.400 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2011 | 37 | 0.380 |
Why?
|
| Athletic Injuries | 1 | 2021 | 1216 | 0.380 |
Why?
|
| Lymphangioleiomyomatosis | 3 | 2010 | 204 | 0.370 |
Why?
|
| Obesity | 3 | 2024 | 12937 | 0.370 |
Why?
|
| Osteosarcoma | 1 | 2017 | 896 | 0.370 |
Why?
|
| Prostatic Hyperplasia | 1 | 2015 | 521 | 0.370 |
Why?
|
| Dinoprost | 1 | 2011 | 139 | 0.370 |
Why?
|
| Mice, Nude | 8 | 2020 | 3604 | 0.360 |
Why?
|
| Polymers | 7 | 2007 | 1617 | 0.360 |
Why?
|
| Glioblastoma | 3 | 2019 | 3481 | 0.360 |
Why?
|
| Humans | 110 | 2024 | 761098 | 0.350 |
Why?
|
| Endothelium | 4 | 2019 | 763 | 0.350 |
Why?
|
| Brain Concussion | 1 | 2021 | 1404 | 0.350 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2011 | 1084 | 0.340 |
Why?
|
| Peptide Hydrolases | 3 | 2006 | 616 | 0.330 |
Why?
|
| Carcinoma, Lewis Lung | 4 | 2003 | 108 | 0.330 |
Why?
|
| Piperidines | 1 | 2018 | 1656 | 0.330 |
Why?
|
| Uterine Diseases | 1 | 2010 | 108 | 0.330 |
Why?
|
| RNA, Small Interfering | 6 | 2019 | 3409 | 0.330 |
Why?
|
| Endothelial Growth Factors | 5 | 2003 | 672 | 0.330 |
Why?
|
| CA-125 Antigen | 1 | 2011 | 276 | 0.320 |
Why?
|
| Adenocarcinoma | 3 | 2015 | 6340 | 0.310 |
Why?
|
| Nanomedicine | 3 | 2020 | 289 | 0.310 |
Why?
|
| Estrogen Receptor alpha | 2 | 2009 | 582 | 0.300 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 380 | 0.300 |
Why?
|
| Stomach Neoplasms | 2 | 2017 | 1458 | 0.300 |
Why?
|
| Metalloproteases | 1 | 2008 | 61 | 0.300 |
Why?
|
| Female | 62 | 2024 | 392458 | 0.300 |
Why?
|
| Neoplasm Proteins | 3 | 2011 | 3594 | 0.300 |
Why?
|
| Polyesters | 3 | 2005 | 371 | 0.300 |
Why?
|
| Cells, Cultured | 22 | 2017 | 18926 | 0.290 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 1141 | 0.280 |
Why?
|
| Glycoproteins | 8 | 2011 | 2203 | 0.280 |
Why?
|
| Liver Regeneration | 2 | 2008 | 213 | 0.280 |
Why?
|
| Pharynx | 2 | 2007 | 432 | 0.280 |
Why?
|
| Matrix Metalloproteinase 1 | 6 | 2007 | 145 | 0.270 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2007 | 1168 | 0.270 |
Why?
|
| Amino Acid Sequence | 16 | 2014 | 13404 | 0.270 |
Why?
|
| Protease Inhibitors | 6 | 2010 | 752 | 0.260 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 5300 | 0.260 |
Why?
|
| Mice | 37 | 2022 | 81324 | 0.260 |
Why?
|
| Mouth | 2 | 2007 | 381 | 0.260 |
Why?
|
| Oligopeptides | 1 | 2011 | 1178 | 0.260 |
Why?
|
| Tissue Engineering | 6 | 2010 | 1865 | 0.260 |
Why?
|
| Pyridines | 1 | 2018 | 2872 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2019 | 8529 | 0.260 |
Why?
|
| Antineoplastic Agents | 8 | 2020 | 13630 | 0.260 |
Why?
|
| Urinary Tract | 2 | 2017 | 304 | 0.260 |
Why?
|
| Molecular Sequence Data | 16 | 2014 | 17598 | 0.260 |
Why?
|
| Cell Division | 13 | 2005 | 4451 | 0.260 |
Why?
|
| Vascular Endothelial Growth Factors | 5 | 2022 | 748 | 0.260 |
Why?
|
| MicroRNAs | 2 | 2020 | 3758 | 0.250 |
Why?
|
| Doxorubicin | 3 | 2019 | 2224 | 0.250 |
Why?
|
| Polydioxanone | 1 | 2005 | 8 | 0.250 |
Why?
|
| Ureteral Obstruction | 2 | 2022 | 293 | 0.250 |
Why?
|
| Sturge-Weber Syndrome | 2 | 2018 | 89 | 0.240 |
Why?
|
| Neoplasm Transplantation | 4 | 2017 | 2010 | 0.240 |
Why?
|
| Bioprosthesis | 2 | 2010 | 591 | 0.240 |
Why?
|
| Neoplasm Invasiveness | 6 | 2024 | 3591 | 0.240 |
Why?
|
| Blotting, Western | 11 | 2014 | 5033 | 0.240 |
Why?
|
| Absorbable Implants | 5 | 2006 | 338 | 0.230 |
Why?
|
| Craniopharyngioma | 1 | 2007 | 276 | 0.230 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2011 | 926 | 0.230 |
Why?
|
| Doxycycline | 1 | 2006 | 344 | 0.230 |
Why?
|
| Respiratory System | 1 | 2007 | 562 | 0.230 |
Why?
|
| Estrogens | 1 | 2011 | 1521 | 0.230 |
Why?
|
| Cloning, Molecular | 8 | 2005 | 4168 | 0.230 |
Why?
|
| Mouth Mucosa | 1 | 2007 | 432 | 0.230 |
Why?
|
| Colonic Polyps | 1 | 2009 | 553 | 0.230 |
Why?
|
| Microscopy, Atomic Force | 2 | 2018 | 252 | 0.230 |
Why?
|
| Molecular Weight | 6 | 2008 | 2171 | 0.220 |
Why?
|
| Vascular Neoplasms | 1 | 2005 | 166 | 0.220 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 1902 | 0.220 |
Why?
|
| DNA, Complementary | 6 | 2007 | 1989 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2024 | 2455 | 0.220 |
Why?
|
| Gelatin | 6 | 2007 | 221 | 0.210 |
Why?
|
| Culture Media, Conditioned | 4 | 2020 | 522 | 0.210 |
Why?
|
| Prostatic Neoplasms | 5 | 2015 | 11103 | 0.210 |
Why?
|
| Down-Regulation | 4 | 2019 | 2915 | 0.210 |
Why?
|
| RNA, Messenger | 14 | 2014 | 12743 | 0.210 |
Why?
|
| Proteomics | 4 | 2021 | 3836 | 0.210 |
Why?
|
| Cell Culture Techniques | 3 | 2007 | 1662 | 0.210 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1602 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2017 | 3803 | 0.200 |
Why?
|
| Peptide Fragments | 6 | 2003 | 5103 | 0.200 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2022 | 60 | 0.200 |
Why?
|
| Case-Control Studies | 8 | 2018 | 22157 | 0.200 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2001 | 328 | 0.200 |
Why?
|
| Signal Transduction | 11 | 2024 | 23415 | 0.200 |
Why?
|
| Proteins | 7 | 2009 | 5993 | 0.200 |
Why?
|
| Hepatectomy | 2 | 2008 | 557 | 0.200 |
Why?
|
| Endometriosis | 1 | 2010 | 857 | 0.190 |
Why?
|
| ROC Curve | 3 | 2015 | 3582 | 0.190 |
Why?
|
| Repressor Proteins | 1 | 2012 | 2974 | 0.190 |
Why?
|
| Mice, Obese | 1 | 2022 | 418 | 0.190 |
Why?
|
| Syndrome | 4 | 2021 | 3269 | 0.190 |
Why?
|
| Gastrointestinal Tract | 1 | 2007 | 834 | 0.190 |
Why?
|
| Molecular Targeted Therapy | 5 | 2019 | 2813 | 0.190 |
Why?
|
| Collagenases | 4 | 1998 | 222 | 0.190 |
Why?
|
| Hydroxamic Acids | 4 | 2010 | 479 | 0.190 |
Why?
|
| Antibodies | 2 | 2019 | 2415 | 0.180 |
Why?
|
| Colon | 1 | 2009 | 1791 | 0.180 |
Why?
|
| Hydronephrosis | 1 | 2022 | 271 | 0.180 |
Why?
|
| Growth Substances | 2 | 1995 | 759 | 0.180 |
Why?
|
| Esophagus | 1 | 2007 | 1033 | 0.180 |
Why?
|
| Lymphokines | 4 | 2003 | 925 | 0.180 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 1201 | 0.180 |
Why?
|
| Protein Array Analysis | 2 | 2015 | 399 | 0.170 |
Why?
|
| Allantois | 4 | 2003 | 32 | 0.170 |
Why?
|
| Base Sequence | 8 | 2012 | 12404 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2004 | 829 | 0.170 |
Why?
|
| SNARE Proteins | 1 | 2019 | 79 | 0.170 |
Why?
|
| Wound Healing | 4 | 2014 | 2801 | 0.170 |
Why?
|
| Rats | 10 | 2007 | 23713 | 0.170 |
Why?
|
| Caveolins | 1 | 2019 | 102 | 0.160 |
Why?
|
| Gene Expression Regulation | 5 | 2012 | 11856 | 0.160 |
Why?
|
| Port-Wine Stain | 1 | 2018 | 33 | 0.160 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 3869 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2023 | 3591 | 0.160 |
Why?
|
| Interleukin-6 | 3 | 2024 | 3210 | 0.160 |
Why?
|
| Burkitt Lymphoma | 1 | 2001 | 335 | 0.160 |
Why?
|
| Pneumonia, Bacterial | 1 | 2021 | 316 | 0.150 |
Why?
|
| Pituitary Neoplasms | 1 | 2007 | 1323 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2007 | 8164 | 0.150 |
Why?
|
| Vascular Diseases | 2 | 2005 | 1160 | 0.150 |
Why?
|
| Filipin | 1 | 2018 | 13 | 0.150 |
Why?
|
| Receptors, CXCR4 | 2 | 2014 | 727 | 0.150 |
Why?
|
| Lipids | 2 | 2019 | 3330 | 0.150 |
Why?
|
| Basement Membrane | 1 | 1999 | 348 | 0.150 |
Why?
|
| Prognosis | 9 | 2021 | 29672 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 4565 | 0.150 |
Why?
|
| Arachidonic Acid | 1 | 2019 | 427 | 0.150 |
Why?
|
| Chlorpromazine | 1 | 2018 | 111 | 0.150 |
Why?
|
| Male | 42 | 2022 | 360675 | 0.150 |
Why?
|
| Angiostatins | 6 | 2012 | 64 | 0.150 |
Why?
|
| Myoglobin | 1 | 2018 | 159 | 0.150 |
Why?
|
| Sheep | 8 | 2010 | 1436 | 0.150 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2019 | 245 | 0.150 |
Why?
|
| Interleukin-1alpha | 1 | 2018 | 86 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2008 | 2223 | 0.150 |
Why?
|
| Collagen | 7 | 2006 | 2635 | 0.150 |
Why?
|
| Tissue Kallikreins | 1 | 2017 | 14 | 0.140 |
Why?
|
| Epithelial Cells | 2 | 2007 | 3666 | 0.140 |
Why?
|
| Enzyme Inhibitors | 8 | 2018 | 3700 | 0.140 |
Why?
|
| Hydrazones | 1 | 2018 | 103 | 0.140 |
Why?
|
| Interleukin-7 | 1 | 2018 | 143 | 0.140 |
Why?
|
| Mice, SCID | 2 | 2014 | 2621 | 0.140 |
Why?
|
| Lung Neoplasms | 8 | 2019 | 13382 | 0.140 |
Why?
|
| Oncogene Proteins | 1 | 2001 | 717 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 9 | 2015 | 6123 | 0.140 |
Why?
|
| DNA Primers | 4 | 2012 | 2815 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2022 | 5662 | 0.140 |
Why?
|
| beta 2-Microglobulin | 1 | 2018 | 329 | 0.140 |
Why?
|
| Lamin Type A | 1 | 2018 | 187 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2015 | 9278 | 0.140 |
Why?
|
| Endosomes | 1 | 2019 | 518 | 0.140 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2005 | 254 | 0.130 |
Why?
|
| Quinazolines | 2 | 2015 | 1371 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2004 | 1731 | 0.130 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 14607 | 0.130 |
Why?
|
| Cell Line | 5 | 2019 | 15542 | 0.130 |
Why?
|
| Isoenzymes | 2 | 2011 | 1682 | 0.130 |
Why?
|
| Ovary | 2 | 2019 | 957 | 0.130 |
Why?
|
| Kinetics | 4 | 2010 | 6312 | 0.130 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2011 | 138 | 0.130 |
Why?
|
| Proteinuria | 1 | 2018 | 604 | 0.130 |
Why?
|
| Interleukin-13 | 1 | 2018 | 392 | 0.130 |
Why?
|
| Capillaries | 5 | 2006 | 755 | 0.130 |
Why?
|
| Aqueous Humor | 1 | 1996 | 153 | 0.130 |
Why?
|
| Brain Neoplasms | 3 | 2019 | 9025 | 0.130 |
Why?
|
| Virus Internalization | 1 | 2019 | 496 | 0.130 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2018 | 354 | 0.120 |
Why?
|
| Chickens | 2 | 2015 | 857 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2015 | 546 | 0.120 |
Why?
|
| Gelatinases | 5 | 2000 | 88 | 0.120 |
Why?
|
| Microcirculation | 4 | 2010 | 1280 | 0.120 |
Why?
|
| Proteome | 2 | 2015 | 1856 | 0.120 |
Why?
|
| Semaphorins | 1 | 2015 | 96 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 316 | 0.120 |
Why?
|
| Protein Transport | 2 | 2019 | 1959 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2005 | 1585 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 4340 | 0.120 |
Why?
|
| Troponin I | 1 | 1999 | 652 | 0.120 |
Why?
|
| Fibroblasts | 5 | 2011 | 4137 | 0.120 |
Why?
|
| Immunohistochemistry | 8 | 2012 | 11066 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 22129 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2012 | 619 | 0.110 |
Why?
|
| Dioxanes | 2 | 2005 | 36 | 0.110 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2012 | 854 | 0.110 |
Why?
|
| Gene Expression | 6 | 2012 | 7567 | 0.110 |
Why?
|
| Athletes | 1 | 2021 | 1138 | 0.110 |
Why?
|
| Cholesterol, Dietary | 1 | 2014 | 224 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 2423 | 0.110 |
Why?
|
| Cell Physiological Phenomena | 1 | 1995 | 149 | 0.110 |
Why?
|
| Cell Adhesion | 5 | 2005 | 3090 | 0.110 |
Why?
|
| Cardiovascular System | 1 | 2001 | 836 | 0.110 |
Why?
|
| Biocompatible Materials | 3 | 2005 | 1684 | 0.110 |
Why?
|
| Cisplatin | 1 | 2019 | 1651 | 0.110 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 18217 | 0.110 |
Why?
|
| Neuroglia | 1 | 2019 | 954 | 0.110 |
Why?
|
| Materials Testing | 3 | 2006 | 866 | 0.110 |
Why?
|
| Growth Inhibitors | 2 | 1994 | 374 | 0.110 |
Why?
|
| Azetidines | 1 | 2014 | 142 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2020 | 2706 | 0.110 |
Why?
|
| Lysophospholipids | 1 | 2015 | 337 | 0.100 |
Why?
|
| Child | 12 | 2022 | 80134 | 0.100 |
Why?
|
| Stem Cells | 3 | 2015 | 3512 | 0.100 |
Why?
|
| Umbilical Veins | 2 | 2010 | 423 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2015 | 10755 | 0.100 |
Why?
|
| Kidney | 5 | 2022 | 7034 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 6198 | 0.100 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 11118 | 0.100 |
Why?
|
| Disease Progression | 8 | 2019 | 13506 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1703 | 0.100 |
Why?
|
| Apoptosis | 5 | 2014 | 9478 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 2017 | 9185 | 0.090 |
Why?
|
| Phenanthrolines | 2 | 2004 | 49 | 0.090 |
Why?
|
| Tretinoin | 1 | 1994 | 517 | 0.090 |
Why?
|
| Vitamin A | 1 | 1994 | 612 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 799 | 0.090 |
Why?
|
| Urinary Bladder | 1 | 1997 | 1152 | 0.090 |
Why?
|
| Adult | 17 | 2021 | 221083 | 0.090 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 161 | 0.090 |
Why?
|
| Open Reading Frames | 3 | 2001 | 811 | 0.090 |
Why?
|
| Enzyme Assays | 1 | 2011 | 104 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2011 | 1650 | 0.090 |
Why?
|
| Child, Preschool | 7 | 2022 | 42217 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2010 | 3779 | 0.090 |
Why?
|
| Fetal Diseases | 2 | 2010 | 912 | 0.090 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 65 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2009 | 12096 | 0.090 |
Why?
|
| Fibrosarcoma | 2 | 2003 | 308 | 0.090 |
Why?
|
| Chick Embryo | 6 | 2003 | 977 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7405 | 0.090 |
Why?
|
| Substrate Specificity | 3 | 2007 | 1768 | 0.090 |
Why?
|
| Pregnancy, Animal | 1 | 2010 | 124 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2019 | 3388 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2020 | 2477 | 0.080 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2011 | 309 | 0.080 |
Why?
|
| Protein Binding | 2 | 2012 | 9300 | 0.080 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 6507 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 359 | 0.080 |
Why?
|
| Collagen Type IV | 2 | 2012 | 125 | 0.080 |
Why?
|
| Venules | 1 | 2009 | 161 | 0.080 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 420 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2003 | 636 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 5775 | 0.080 |
Why?
|
| Neoplasms, Experimental | 4 | 2002 | 1225 | 0.080 |
Why?
|
| Glaucoma | 1 | 2018 | 1186 | 0.080 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2009 | 188 | 0.080 |
Why?
|
| Cell Count | 3 | 2007 | 1831 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2091 | 0.080 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2010 | 664 | 0.080 |
Why?
|
| Medical Oncology | 1 | 2020 | 2316 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 677 | 0.080 |
Why?
|
| Enzyme Activation | 5 | 2005 | 3577 | 0.080 |
Why?
|
| Cathepsins | 1 | 2009 | 241 | 0.080 |
Why?
|
| Tibia | 1 | 2014 | 1070 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4933 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 2401 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2003 | 2741 | 0.070 |
Why?
|
| Cell Lineage | 1 | 2017 | 2547 | 0.070 |
Why?
|
| Liver | 2 | 2018 | 7513 | 0.070 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 2067 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 1249 | 0.070 |
Why?
|
| Young Adult | 7 | 2021 | 59199 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2022 | 54419 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2010 | 684 | 0.070 |
Why?
|
| Aged | 12 | 2017 | 169266 | 0.070 |
Why?
|
| Densitometry | 2 | 2004 | 151 | 0.070 |
Why?
|
| Area Under Curve | 1 | 2011 | 1636 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 1348 | 0.070 |
Why?
|
| Reference Values | 2 | 2009 | 4922 | 0.070 |
Why?
|
| Dimerization | 1 | 2008 | 888 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 915 | 0.070 |
Why?
|
| Adolescent | 8 | 2018 | 88271 | 0.070 |
Why?
|
| Middle Aged | 13 | 2018 | 220835 | 0.070 |
Why?
|
| Melanocytes | 2 | 2017 | 509 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 5781 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 1751 | 0.070 |
Why?
|
| Pericardium | 1 | 2011 | 674 | 0.070 |
Why?
|
| Plastics | 1 | 2007 | 117 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2011 | 965 | 0.070 |
Why?
|
| Disintegrins | 1 | 2006 | 27 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 873 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 426 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 3821 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 1240 | 0.070 |
Why?
|
| Peptides | 2 | 2004 | 4353 | 0.060 |
Why?
|
| Biodegradation, Environmental | 2 | 2003 | 216 | 0.060 |
Why?
|
| Hemangioma | 2 | 2015 | 727 | 0.060 |
Why?
|
| Mesoderm | 1 | 2009 | 673 | 0.060 |
Why?
|
| Bone Marrow | 2 | 2020 | 2911 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 944 | 0.060 |
Why?
|
| Phenotype | 7 | 2010 | 16572 | 0.060 |
Why?
|
| Chorion | 3 | 2003 | 112 | 0.060 |
Why?
|
| Keratins | 1 | 2007 | 498 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2010 | 821 | 0.060 |
Why?
|
| Logistic Models | 2 | 2011 | 13254 | 0.060 |
Why?
|
| Cholesterol | 1 | 2014 | 2902 | 0.060 |
Why?
|
| Chromatography, Affinity | 2 | 2004 | 525 | 0.060 |
Why?
|
| Prolactin | 1 | 2007 | 625 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2006 | 175 | 0.060 |
Why?
|
| Epidermal Growth Factor | 2 | 1998 | 699 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 191 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 14676 | 0.060 |
Why?
|
| Sclerotherapy | 1 | 2006 | 182 | 0.060 |
Why?
|
| Rare Diseases | 1 | 2010 | 623 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2005 | 1644 | 0.060 |
Why?
|
| Electrophoresis | 1 | 2004 | 225 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2020 | 4642 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2009 | 11505 | 0.060 |
Why?
|
| Surface Properties | 1 | 2007 | 1162 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2004 | 294 | 0.060 |
Why?
|
| Sepharose | 1 | 2004 | 102 | 0.060 |
Why?
|
| Ligands | 2 | 2009 | 3266 | 0.060 |
Why?
|
| Ultracentrifugation | 1 | 2004 | 182 | 0.060 |
Why?
|
| Cyclohexanes | 1 | 2004 | 151 | 0.060 |
Why?
|
| Caseins | 1 | 2004 | 104 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 9566 | 0.060 |
Why?
|
| Edetic Acid | 1 | 2004 | 275 | 0.060 |
Why?
|
| Binding Sites | 1 | 2012 | 5993 | 0.060 |
Why?
|
| Lymphatic Abnormalities | 1 | 2005 | 134 | 0.060 |
Why?
|
| Sesquiterpenes | 1 | 2004 | 176 | 0.060 |
Why?
|
| Skin Absorption | 1 | 2003 | 94 | 0.050 |
Why?
|
| Leg Ulcer | 1 | 2003 | 71 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3598 | 0.050 |
Why?
|
| Awards and Prizes | 1 | 2008 | 362 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2007 | 659 | 0.050 |
Why?
|
| Fibronectins | 2 | 2004 | 724 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2010 | 1026 | 0.050 |
Why?
|
| Epilepsy | 1 | 2018 | 3304 | 0.050 |
Why?
|
| Lymphangiogenesis | 1 | 2004 | 171 | 0.050 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2003 | 158 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 2 | 2005 | 4739 | 0.050 |
Why?
|
| Chelating Agents | 1 | 2004 | 383 | 0.050 |
Why?
|
| Catalysis | 1 | 2004 | 763 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2011 | 2208 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 502 | 0.050 |
Why?
|
| Endometrial Neoplasms | 1 | 2012 | 1365 | 0.050 |
Why?
|
| Elastin | 2 | 2001 | 298 | 0.050 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2011 | 1520 | 0.050 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2006 | 324 | 0.050 |
Why?
|
| COS Cells | 1 | 2004 | 1129 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2003 | 464 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2004 | 473 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2009 | 1496 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2015 | 1480 | 0.050 |
Why?
|
| Carcinoma in Situ | 1 | 2008 | 791 | 0.050 |
Why?
|
| Myocardium | 2 | 2011 | 4746 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4405 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2010 | 2802 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 1186 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 1666 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 841 | 0.050 |
Why?
|
| Chorioallantoic Membrane | 2 | 2015 | 50 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 3419 | 0.050 |
Why?
|
| Calciphylaxis | 1 | 2003 | 130 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2014 | 2045 | 0.050 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2002 | 94 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2008 | 1566 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2008 | 15308 | 0.050 |
Why?
|
| Dietary Carbohydrates | 1 | 2006 | 891 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 2003 | 713 | 0.050 |
Why?
|
| Hydroxyproline | 1 | 2001 | 110 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 12058 | 0.050 |
Why?
|
| Time Factors | 7 | 2015 | 39953 | 0.050 |
Why?
|
| Actins | 2 | 2007 | 2046 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2009 | 9416 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2007 | 1967 | 0.050 |
Why?
|
| Kidney Pelvis | 1 | 2022 | 186 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12975 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2002 | 1083 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 982 | 0.050 |
Why?
|
| Zebrafish | 1 | 2012 | 3001 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2001 | 218 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2009 | 6067 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2004 | 616 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 1463 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 2913 | 0.050 |
Why?
|
| Proteoglycans | 2 | 2001 | 803 | 0.050 |
Why?
|
| Iron | 1 | 2009 | 1790 | 0.050 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2003 | 311 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2001 | 812 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2001 | 193 | 0.040 |
Why?
|
| Gene Library | 1 | 2003 | 1055 | 0.040 |
Why?
|
| Heparin | 2 | 1998 | 1632 | 0.040 |
Why?
|
| Microspheres | 1 | 2003 | 783 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 748 | 0.040 |
Why?
|
| Hydrogels | 1 | 2006 | 720 | 0.040 |
Why?
|
| Protective Agents | 1 | 2001 | 150 | 0.040 |
Why?
|
| Zinc | 1 | 2004 | 672 | 0.040 |
Why?
|
| Infant | 5 | 2018 | 36164 | 0.040 |
Why?
|
| Cranial Nerve Injuries | 1 | 2000 | 28 | 0.040 |
Why?
|
| Culture Techniques | 1 | 2000 | 531 | 0.040 |
Why?
|
| Lingual Nerve | 1 | 2000 | 31 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 2006 | 961 | 0.040 |
Why?
|
| Cell Survival | 2 | 2012 | 5776 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2006 | 789 | 0.040 |
Why?
|
| Taste Disorders | 1 | 2000 | 38 | 0.040 |
Why?
|
| United States | 3 | 2021 | 72337 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2008 | 2764 | 0.040 |
Why?
|
| Polyglactin 910 | 1 | 1999 | 55 | 0.040 |
Why?
|
| Pancreatic Elastase | 1 | 1999 | 126 | 0.040 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2004 | 528 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2004 | 1818 | 0.040 |
Why?
|
| Bucladesine | 1 | 1999 | 118 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6224 | 0.040 |
Why?
|
| 5' Untranslated Regions | 1 | 2001 | 251 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2002 | 460 | 0.040 |
Why?
|
| Urethral Obstruction | 1 | 1999 | 55 | 0.040 |
Why?
|
| Plasmids | 1 | 2004 | 2261 | 0.040 |
Why?
|
| Fibrosis | 3 | 2010 | 2051 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2092 | 0.040 |
Why?
|
| Hemangioendothelioma | 1 | 1999 | 111 | 0.040 |
Why?
|
| Homeostasis | 2 | 2011 | 3318 | 0.040 |
Why?
|
| Membranes, Artificial | 1 | 2000 | 366 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1999 | 240 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2021 | 745 | 0.040 |
Why?
|
| Transplantation, Autologous | 2 | 2000 | 2112 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2001 | 514 | 0.040 |
Why?
|
| Taste | 1 | 2000 | 189 | 0.040 |
Why?
|
| Sex Factors | 2 | 2018 | 10552 | 0.040 |
Why?
|
| Hemangiosarcoma | 1 | 2000 | 215 | 0.040 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1998 | 124 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 858 | 0.040 |
Why?
|
| Rabbits | 3 | 2012 | 4749 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 4612 | 0.040 |
Why?
|
| Cornea | 3 | 2004 | 1330 | 0.040 |
Why?
|
| Transfection | 1 | 2005 | 5750 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2000 | 457 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2001 | 548 | 0.040 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 1997 | 80 | 0.040 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1997 | 68 | 0.030 |
Why?
|
| Endostatins | 2 | 2012 | 168 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 1999 | 625 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 484 | 0.030 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 6817 | 0.030 |
Why?
|
| Adrenal Cortex | 2 | 2003 | 134 | 0.030 |
Why?
|
| Fetus | 2 | 2010 | 1862 | 0.030 |
Why?
|
| Estrus | 1 | 1996 | 70 | 0.030 |
Why?
|
| Stroke | 1 | 2018 | 9720 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 58946 | 0.030 |
Why?
|
| Extracellular Space | 1 | 1998 | 563 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2008 | 1921 | 0.030 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1997 | 257 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2003 | 2820 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1696 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 2020 | 566 | 0.030 |
Why?
|
| Leukemia Virus, Murine | 1 | 2016 | 94 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2008 | 2279 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2009 | 8639 | 0.030 |
Why?
|
| Receptors, Cannabinoid | 1 | 2015 | 43 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2000 | 951 | 0.030 |
Why?
|
| Neoplasms, Vascular Tissue | 1 | 2015 | 25 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2003 | 1086 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 1999 | 941 | 0.030 |
Why?
|
| Thiazoles | 1 | 2002 | 1517 | 0.030 |
Why?
|
| Sarcoma 180 | 1 | 1994 | 6 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 39121 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 389 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 2381 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 1994 | 47 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2005 | 3111 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 1994 | 116 | 0.030 |
Why?
|
| Women's Health | 1 | 2004 | 2068 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 2138 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1998 | 2175 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1998 | 1202 | 0.030 |
Why?
|
| Brain Stem | 1 | 2018 | 858 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 30006 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2006 | 2492 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2003 | 2075 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 613 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 2014 | 378 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 2914 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1996 | 1162 | 0.030 |
Why?
|
| Genomics | 1 | 2008 | 5828 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2001 | 2881 | 0.030 |
Why?
|
| Aging | 1 | 2011 | 8701 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 681 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2000 | 1927 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 1790 | 0.020 |
Why?
|
| Heart Rate | 1 | 2003 | 4196 | 0.020 |
Why?
|
| Age of Onset | 1 | 2018 | 3307 | 0.020 |
Why?
|
| Creatinine | 2 | 2010 | 1897 | 0.020 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15845 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 1187 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2003 | 2528 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 928 | 0.020 |
Why?
|
| Oncogenes | 1 | 1997 | 1220 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1999 | 1818 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1996 | 1963 | 0.020 |
Why?
|
| Scapula | 1 | 1992 | 173 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2013 | 24013 | 0.020 |
Why?
|
| Swine | 2 | 2003 | 5909 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2012 | 255 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2021 | 9317 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2010 | 2057 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1053 | 0.020 |
Why?
|
| Matrix Metalloproteinases, Secreted | 1 | 2010 | 13 | 0.020 |
Why?
|
| Incidence | 1 | 2008 | 21357 | 0.020 |
Why?
|
| Cystatin A | 1 | 2009 | 6 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2014 | 1756 | 0.020 |
Why?
|
| Cystatin B | 1 | 2009 | 12 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1999 | 2160 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2468 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 2478 | 0.020 |
Why?
|
| Heart Injuries | 1 | 2011 | 206 | 0.020 |
Why?
|
| Pressure | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2359 | 0.020 |
Why?
|
| Neutrophils | 1 | 2001 | 3763 | 0.020 |
Why?
|
| Age Factors | 1 | 2005 | 18385 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2003 | 1900 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1995 | 1488 | 0.020 |
Why?
|
| Autoantigens | 1 | 2012 | 887 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 1 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2009 | 199 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2008 | 26187 | 0.020 |
Why?
|
| Models, Biological | 3 | 2012 | 9455 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1994 | 1434 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1991 | 961 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2015 | 4014 | 0.020 |
Why?
|
| Biological Assay | 1 | 1990 | 623 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1992 | 2666 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 918 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2008 | 270 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2008 | 524 | 0.020 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2005 | 60 | 0.020 |
Why?
|
| Peptide Library | 1 | 2007 | 347 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2008 | 344 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 471 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 475 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 711 | 0.020 |
Why?
|
| Growth Hormone | 1 | 2007 | 569 | 0.020 |
Why?
|
| Calcium | 1 | 1998 | 5720 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2005 | 210 | 0.010 |
Why?
|
| Polystyrenes | 1 | 2005 | 104 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2004 | 63 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 1990 | 863 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2004 | 127 | 0.010 |
Why?
|
| Dipeptides | 1 | 2005 | 387 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2009 | 944 | 0.010 |
Why?
|
| Transducers | 1 | 2004 | 244 | 0.010 |
Why?
|
| Periodicity | 1 | 2004 | 347 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1520 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2004 | 517 | 0.010 |
Why?
|
| Injections | 1 | 2006 | 832 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2010 | 1266 | 0.010 |
Why?
|
| Melanoma | 2 | 2017 | 5694 | 0.010 |
Why?
|
| Organ Size | 1 | 2008 | 2253 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 1113 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1737 | 0.010 |
Why?
|
| Elasticity | 1 | 2004 | 655 | 0.010 |
Why?
|
| Corneal Neovascularization | 1 | 2004 | 185 | 0.010 |
Why?
|
| Homozygote | 1 | 2007 | 1775 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2009 | 1607 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 286 | 0.010 |
Why?
|
| Sirolimus | 1 | 2009 | 1540 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8519 | 0.010 |
Why?
|
| Prostate | 1 | 2010 | 1772 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 1761 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2010 | 1754 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6482 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3429 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1668 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1998 | 4251 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2003 | 319 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 6178 | 0.010 |
Why?
|
| Agar | 1 | 2000 | 51 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2011 | 3430 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2002 | 325 | 0.010 |
Why?
|
| Chromones | 1 | 2000 | 148 | 0.010 |
Why?
|
| Echocardiography | 2 | 2005 | 5006 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 2000 | 167 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1544 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10758 | 0.010 |
Why?
|
| Collagen Type XVIII | 1 | 1999 | 52 | 0.010 |
Why?
|
| Larynx | 1 | 2005 | 492 | 0.010 |
Why?
|
| Porosity | 1 | 2000 | 348 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 1674 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6585 | 0.010 |
Why?
|
| Trachea | 1 | 2005 | 1090 | 0.010 |
Why?
|
| Cell Size | 1 | 2000 | 625 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2002 | 558 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 2262 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2005 | 1270 | 0.010 |
Why?
|
| Pregnancy | 2 | 2010 | 29872 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2000 | 850 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2000 | 737 | 0.010 |
Why?
|
| Heart | 1 | 2011 | 4431 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2000 | 607 | 0.010 |
Why?
|
| Biotechnology | 1 | 1999 | 281 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 1999 | 472 | 0.010 |
Why?
|
| Skin | 1 | 2011 | 4473 | 0.010 |
Why?
|
| Morpholines | 1 | 2000 | 581 | 0.010 |
Why?
|
| Flavonoids | 1 | 2000 | 444 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 36418 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1993 | 3754 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1999 | 419 | 0.010 |
Why?
|
| Lung | 1 | 1996 | 9979 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 4618 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 818 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1997 | 358 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1997 | 291 | 0.010 |
Why?
|
| Veins | 1 | 2000 | 767 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1999 | 911 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1999 | 537 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 8303 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 864 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1996 | 861 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 927 | 0.010 |
Why?
|
| Androstadienes | 1 | 1997 | 348 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1998 | 857 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 433 | 0.010 |
Why?
|
| Heparin Lyase | 1 | 1994 | 37 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 1997 | 656 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2002 | 1624 | 0.010 |
Why?
|
| Microsurgery | 1 | 2000 | 793 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2001 | 1498 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 6781 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1998 | 1132 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1994 | 642 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 14393 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1998 | 1498 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2000 | 2926 | 0.010 |
Why?
|
| Histones | 1 | 2003 | 2570 | 0.010 |
Why?
|
| Weight Loss | 1 | 2003 | 2680 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2011 | 64670 | 0.010 |
Why?
|
| Progesterone | 1 | 1996 | 742 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1994 | 1535 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 11475 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 3725 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1997 | 3665 | 0.000 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1997 | 2864 | 0.000 |
Why?
|
| DNA | 1 | 1999 | 7189 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2000 | 80673 | 0.000 |
Why?
|